Concepedia

Chantale Blattler

CB

Statistics

Publications

7

Citations

345

H-Index

7

Active since

2003

Affiliations

Princess Margaret Cancer Centre(Current)

National Cancer Institute

Juravinski Cancer Centre

University of Calgary

Ontario Institute for Cancer Research

Chantale Blattler is an author at Princess Margaret Cancer Centre specializing in medicine, oncology, and cancer pharmacology.

Publications per year

2003–2016

7

Publications

7

A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia

Iván Díaz-Padilla, Michelle Wilson, Blaise Clarke et al. · Gynecologic Oncology · 2015 · 81 citations

, , +17

A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium

Srikala S. Sridhar, Eric Winquist, Andrea Eisen et al. · Investigational New Drugs · 2010 · 77 citations

, , +14

A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: A study of the Princess Margaret, Chicago and California Consortia

Vincent Castonguay, Stéphanie Lheureux, Stephen Welch et al. · Gynecologic Oncology · 2014 · 59 citations

, , +8

Phase II Trial of Lenalidomide in Patients with Relapsed or Refractory Hodgkin Lymphoma

John Kuruvilla, Diane Taylor, Lisa Wang et al. · Blood · 2008 · 47 citations

, , +12

Oilgomerization characteristics of cysteine string protein

Leigh Anne Swayne, Chantale Blattler, Jason G. Kay et al. · Biochemical and Biophysical Research Communications · 2003 · 31 citations

, , +7

1–5 of 7